This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Aptar’s UDS: The Trusted Platform for Nasal Drug Delivery
Webinars, Pharmaceutical, Product Solutions, Innovation & Insights, Drug Delivery Innovations, Market Insights
Overcoming Challenges in Preclinical Studies for Intranasal and Inhalation Programs
Webinars, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Drug Delivery Innovations
Optimising Preclinical Studies for Intranasal and Pulmonary Programmes
Publications, Pharmaceutical, Market Insights, Product Solutions, Drug Delivery Innovations
Targeted Aerosol Delivery to NALT Using BiVax Intranasal Atomizer
Publications, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions
